Medivir AB Release: Lipsovir(R) Has Entered Phase III Clinical Study
STOCKHOLM, Sweden--(BUSINESS WIRE)--July 6, 2006--LipsovirĀ® (ME-609) is Medivir's labial herpes project. The aim of the phase III study is to show that early initiation of treatment with LipsovirĀ® will prevent the development of labial herpes (cold sores).